Log in to save to my catalogue

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial...

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_af1964c8c71140edae02f0ea5d8b8ec2

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease

About this item

Full title

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease

Publisher

England: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2023-01, Vol.9 (1), p.e002667

Language

English

Formats

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

ObjectiveNo studies have demonstrated the real-world efficacy of antifibrotics for progressive fibrosing interstitial lung disease (PF-ILD). Therefore, we evaluated the efficacy of antifibrotics in patients with PF-ILD.MethodsWe retrospectively reviewed the medical records of patients with ILD from January 2012 to July 2021. Patients were diagnosed...

Alternative Titles

Full title

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_af1964c8c71140edae02f0ea5d8b8ec2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_af1964c8c71140edae02f0ea5d8b8ec2

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2022-002667

How to access this item